ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 110 filers reported holding ERASCA INC in Q3 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $515,508 | -27.5% | 261,679 | +1.5% | 0.00% | – |
Q2 2023 | $711,271 | -3.0% | 257,707 | +5.8% | 0.00% | – |
Q1 2023 | $733,019 | -19.7% | 243,528 | +14.9% | 0.00% | – |
Q4 2022 | $913,350 | -48.7% | 211,914 | -7.2% | 0.00% | – |
Q3 2022 | $1,781,000 | +70.1% | 228,344 | +21.4% | 0.00% | – |
Q2 2022 | $1,047,000 | -41.4% | 188,039 | -9.5% | 0.00% | – |
Q1 2022 | $1,787,000 | +11.8% | 207,693 | +102.4% | 0.00% | – |
Q4 2021 | $1,599,000 | +49.9% | 102,622 | +104.1% | 0.00% | – |
Q3 2021 | $1,067,000 | – | 50,273 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |